Eleva Appoints Martin Bauer, MD as Chief Medical Officer
Eleva Appoints Martin Bauer, MD as Chief Medical Officer Adding [...]
Eleva and 3PBIOVIAN sign strategic alliance
Eleva and 3PBIOVIAN sign strategic GMP manufacturing and technology alliance [...]
Eleva appoints Dr. Elisabeth Lackner to its Supervisory Board
Eleva appoints Dr. Elisabeth Lackner to its Supervisory Board [...]
The New Role(s) of CDMOs In Biopharmaceutical Development
The New Role(s) of CDMOs In Biopharmaceutical Development [...]
Euro Health Leaders features Eleva and CEO Björn Cochlovius
Euro Health Leaders features Eleva and CEO Björn Cochlovius [...]
Eleva Receives Orphan Drug Designation in Europe for Proprietary Factor H Therapy in C3 Glomerulopathy (C3G)
Eleva receives Orphan Drug Designation in Europe for proprietary [...]
Eleva publishes preclinical data on proprietary Factor H therapy
Eleva publishes preclinical data on proprietary Factor H therapy [...]
Eleva appoints Henrik Luessen as new Chief Business Officer
Eleva appoints Henrik Luessen as new Chief Business Officer [...]
Eleva appoints Björn Cochlovius as new Chief Executive Officer
Eleva appoints Björn Cochlovius as new Chief Executive Officer [...]
